{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:28:21Z","timestamp":1793888901443,"version":"4.8.0"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi240562-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) have recently proposed a consensus definition and diagnostic criteria for sarcopenic obesity (SO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240562-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To implement the ESPEN-EASO diagnostic algorithm to investigate the prevalence of SO and its association with outcomes in patients with solid tumor cancers, with particular regard to associations among SO, overall survival (OS), and patient quality of life (QoL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240562-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prospective cohort study included patients diagnosed with solid tumor starting in May 7, 2013, with the last follow-up on June 30, 2022. Patients with solid tumors were categorized into SO and non-SO groups according to ESPEN-EASO criteria. The primary outcome was OS and the secondary outcomes included patient QoL and risk of intensive care unit (ICU) admission. Data were analyzed from June to December 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240562-7\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 6790 patients were included in the study (mean [SD] age, 59.64 [10.77] years; 3489  were female [51.4%]). The prevalence of SO was 4.36% (296 of 6790) in the whole cohort and 14.98% (296 of 1976) in the subgroup with obesity. SO prevalence increased with age. During a median (IQR) follow-up period of 6.83 (5.67-7.04) years, 2103 patients died. Cox regression analysis indicated that SO was independently associated with lower OS (hazard ratio [HR], 1.54; 95% CI, 1.23-1.92), which was observed in both men (HR, 1.51; 95% CI, 1.09-2.10) and women (HR, 1.53; 95% CI, 1.12-2.07). SO was also associated with poorer QoL and higher risk of ICU admission (odds ratio, 2.39; 95% CI, 1.06-5.29). Among the diagnostic components of SO, low hand grip strength (HGS) was the only SO component associated with poor OS (HR, 1.15; 95% CI, 1.04-1.28).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240562-8\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This cohort study of SO found that SO was significantly associated with lower OS, poorer QoL, and higher risk of ICU admission. Weak HGS, 1 of the diagnostic conditions, was the only component of SO associated with OS. The ESPEN-EASO algorithm appears to be an applicable tool to identify cancer-associated SO, which represents a major clinical complication and factor associated with risk for poor outcomes in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.17115","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:31:37Z","timestamp":1718364697000},"page":"e2417115","source":"Crossref","is-referenced-by-count":54,"title":["Sarcopenic Obesity and Outcomes for Patients With Cancer"],"prefix":"10.1001","volume":"7","author":[{"given":"Chenan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China"},{"name":"Laboratory for Clinical Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China"},{"name":"Laboratory for Clinical Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China"},{"name":"Laboratory for Clinical Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Genetics, Yale University School of Medicine, New Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Song","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China"},{"name":"Laboratory for Clinical Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenning","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailun","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China"},{"name":"Laboratory for Clinical Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China"},{"name":"Laboratory for Clinical Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China"},{"name":"Laboratory for Clinical Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China"},{"name":"Laboratory for Clinical Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China"},{"name":"Laboratory for Clinical Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Barazzoni","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanping","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China"},{"name":"Laboratory for Clinical Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"zoi240562r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2022.111728","article-title":"Prevalence of sarcopenic obesity based on newly proposed diagnostic criteria and functional outcomes in older adults undergoing rehabilitation.","volume":"208","author":"Shimizu","year":"2022","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"zoi240562r2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ageing\/afz046","article-title":"Sarcopenia: revised European consensus on definition and diagnosis.","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"3","key":"zoi240562r3","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afae052","article-title":"The conceptual definition of sarcopenia: Delphi consensus from the Global Leadership Initiative in Sarcopenia (GLIS).","volume":"53","author":"Kirk","year":"2024","journal-title":"Age Ageing"},{"issue":"12","key":"zoi240562r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.2319","article-title":"Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study.","volume":"3","author":"Feliciano","year":"2017","journal-title":"JAMA Oncol"},{"issue":"24","key":"zoi240562r5","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.3390\/cancers14246144","article-title":"Effect of sarcopenia on survival and health-related quality of life in patients with hepatocellular carcinoma after hepatectomy.","volume":"14","author":"Hu","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"zoi240562r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27282","article-title":"Predictive impact of sarcopenia in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: a retrospective study.","volume":"10","author":"Feng","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"zoi240562r7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/nu13030761","article-title":"Sarcopenia, malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer.","volume":"13","author":"Meza-Valderrama","year":"2021","journal-title":"Nutrients"},{"key":"zoi240562r8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","article-title":"Obesity and cancer risk: emerging biological mechanisms and perspectives.","volume":"92","author":"Avgerinos","year":"2019","journal-title":"Metabolism"},{"issue":"1","key":"zoi240562r9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/jcsm.13415","article-title":"The age-related obesity paradigm: results from two large prospective cohort studies.","volume":"15","author":"Ge","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"zoi240562r10","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1158\/0008-5472.CAN-17-3590","article-title":"The plausibility of the obesity paradox in cancer-response-reply to point.","volume":"78","author":"Cespedes Feliciano","year":"2018","journal-title":"Cancer Res"},{"issue":"12","key":"zoi240562r11","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/oby.2004.250","article-title":"Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly.","volume":"12","author":"Baumgartner","year":"2004","journal-title":"Obes Res"},{"issue":"4","key":"zoi240562r12","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.clnu.2021.11.014","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.","volume":"41","author":"Donini","year":"2022","journal-title":"Clin Nutr"},{"key":"zoi240562r13","article-title":"Extension protocol for the Investigation on Nutrition Status and Clinical Outcome of Patients with Common Cancers in China (INSCOC) study: 2021 update.","volume":"1","author":"Xu","year":"2022","journal-title":"Precis Nutr"},{"issue":"5","key":"zoi240562r14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/ijo.2015.243","article-title":"Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999-2004.","volume":"40","author":"Batsis","year":"2016","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"zoi240562r15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 Consensus update on sarcopenia diagnosis and treatment.","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"zoi240562r16","doi-asserted-by":"publisher","first-page":"775.e5","DOI":"10.1016\/j.jamda.2013.06.013","article-title":"New normative values for handgrip strength: results from the UK Biobank.","volume":"14","author":"Spruit","year":"2013","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"zoi240562r17","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/ajcn\/72.3.694","article-title":"Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index.","volume":"72","author":"Gallagher","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"zoi240562r18","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.811288","article-title":"Association between systemic inflammation and malnutrition with survival in patients with cancer sarcopenia-A prospective multicenter study.","volume":"8","author":"Ruan","year":"2022","journal-title":"Front Nutr"},{"issue":"7","key":"zoi240562r19","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.2337\/dc10-0107","article-title":"Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA).","volume":"33","author":"Lim","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"zoi240562r20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3961\/jpmph.15.055","article-title":"Associations of sarcopenia and sarcopenic obesity with metabolic syndrome considering both muscle mass and muscle strength.","volume":"49","author":"Lee","year":"2016","journal-title":"J Prev Med Public Health"},{"key":"zoi240562r21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejca.2018.11.024","article-title":"General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.","volume":"107","author":"Nolte","year":"2019","journal-title":"Eur J Cancer"},{"issue":"1","key":"zoi240562r22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ckj\/sfab158","article-title":"An introduction to inverse probability of treatment weighting in observational research.","volume":"15","author":"Chesnaye","year":"2021","journal-title":"Clin Kidney J"},{"issue":"8","key":"zoi240562r23","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1016\/j.clnu.2019.11.024","article-title":"Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review.","volume":"39","author":"Donini","year":"2020","journal-title":"Clin Nutr"},{"issue":"8","key":"zoi240562r24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/ijo.2009.130","article-title":"Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study.","volume":"33","author":"Kim","year":"2009","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"zoi240562r25","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/jgs.2013.61.issue-6","article-title":"Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004.","volume":"61","author":"Batsis","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"19","key":"zoi240562r26","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.3390\/nu14194205","article-title":"The applicability of the ESPEN and EASO-defined diagnostic criteria for sarcopenic obesity in Japanese patients after stroke: prevalence and association with outcomes.","volume":"14","author":"Yoshimura","year":"2022","journal-title":"Nutrients"},{"key":"zoi240562r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155595","article-title":"Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile.","volume":"145","author":"Gortan Cappellari","year":"2023","journal-title":"Metabolism"},{"issue":"9","key":"zoi240562r28","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.clnu.2023.07.014","article-title":"Sarcopenia prevalence and functional outcomes in older men with obesity: comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions.","volume":"42","author":"Scott","year":"2023","journal-title":"Clin Nutr"},{"issue":"4","key":"zoi240562r29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.orcp.2023.08.002","article-title":"Sarcopenic obesity using the ESPEN and EASO consensus statement criteria of 2022\u2014results from the German KORA-Age study.","volume":"17","author":"Schluessel","year":"2023","journal-title":"Obes Res Clin Pract"},{"issue":"1","key":"zoi240562r30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies.","volume":"16","author":"Setiawan","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"5","key":"zoi240562r31","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cvsm.2019.04.008","article-title":"Anorexia and the cancer patient.","volume":"49","author":"Johannes","year":"2019","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"4","key":"zoi240562r32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.clnu.2023.02.021","article-title":"Nutrition impact symptoms: noteworthy prognostic indicators for lung cancer.","volume":"42","author":"Liu","year":"2023","journal-title":"Clin Nutr"},{"issue":"3","key":"zoi240562r33","article-title":"Impact of consuming a Mediterranean-style diet during pregnancy on neurodevelopmental disabilities in offspring: results from the Boston Birth Cohort.","volume":"2","author":"Che","year":"2023","journal-title":"Precis Nutr"},{"issue":"5","key":"zoi240562r34","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3322\/caac.v67.5","article-title":"Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention.","volume":"67","author":"Picon-Ruiz","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"zoi240562r35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"issue":"1","key":"zoi240562r36","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/jcsm.v13.1","article-title":"Absolute and relative grip strength as predictors of cancer: prospective cohort study of 445 552 participants in UK Biobank.","volume":"13","author":"Parra-Soto","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"zoi240562r37","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/jcsm.v12.6","article-title":"Associations of low hand grip strength with 1 year mortality of cancer cachexia: a multicentre observational study.","volume":"12","author":"Song","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"zoi240562r38","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/jcsm.v14.4","article-title":"Hand grip strength in patients with advanced cancer: a prospective study.","volume":"14","author":"Hadzibegovic","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"zoi240562r39","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1186\/s12885-023-11423-y","article-title":"The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer.","volume":"23","author":"Sahin","year":"2023","journal-title":"BMC Cancer"},{"issue":"4","key":"zoi240562r40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/diagnostics9040206","article-title":"Sarcopenic factors may have no impact on outcomes in ovarian cancer patients.","volume":"9","author":"Nakayama","year":"2019","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"zoi240562r41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.5306\/wjco.v12.i5.355","article-title":"Prognostic role of sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy: a retrospective study.","volume":"12","author":"Maddalena","year":"2021","journal-title":"World J Clin Oncol"},{"issue":"14","key":"zoi240562r42","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.3390\/cancers15143538","article-title":"Preoperative CT-based skeletal muscle mass depletion and outcomes after total laryngectomy.","volume":"15","author":"Salati","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"zoi240562r43","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MED.0000000000000360","article-title":"Current body composition measurement techniques.","volume":"24","author":"Lemos","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"zoi240562r44","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.clnu.2023.06.032","article-title":"Sarcopenic obesity and its relation with muscle quality and mortality in patients on chronic hemodialysis.","volume":"42","author":"Sabatino","year":"2023","journal-title":"Clin Nutr"},{"issue":"2","key":"zoi240562r45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12603-014-0530-4","article-title":"Higher levels of physical fitness are associated with a reduced risk of suffering sarcopenic obesity and better perceived health among the elderly: the EXERNET multi-center study.","volume":"19","author":"Pedrero-Chamizo","year":"2015","journal-title":"J Nutr Health Aging"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2820023\/liu_2024_oi_240562_1717774231.7135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:31:43Z","timestamp":1718364703000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2820023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.17115","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}